Novo Nordisk (NVO)
(Delayed Data from NYSE)
$132.06 USD
+0.06 (0.05%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $132.30 +0.24 (0.18%) 7:56 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 32% (79 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.46 | 2.00 | 9.99 |
Current Quarter Estimate | 0.91 | 37.61 | 61.00 |
Year Ago Quarter Estimate | 0.73 | 12.41 | 54.84 |
Next Quarter Estimate | 0.97 | 38.42 | 63.00 |
Next Year Estimate | 4.34 | 173.21 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.19 | 6.60 | 15.67 |
Next Year | 39.55 | 16.80 | 11.34 |
Last 5 Years | 17.00 | 2.90 | 8.10 |
Next 5 Years | 29.40 | 11.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 45.21 | 22.12 |
Price/Book (MRQ) | 36.48 | 5.89 |
Price/Cash Flow (MRFY) | 43.84 | 12.20 |
Dividend Yield | 0.55% | 2.13% |
Net Profit Margin (TTM) | 34.86% | 18.86% |
Return on Equity (TTM) | 87.43% | 34.56% |
Debt to Equity (MRQ) | 0.46 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.